Carbon Footprint Impact, of Monoclonal Antibodies for Severe Asthma, Administered in Italy

Carbon Footprint Impact, of Monoclonal Antibodies for Severe Asthma, Administered in Italy

<b>Background</b>: Severe asthma is a respiratory condition, involving treatments (i.e., inhaled steroids, systemic steroids, hospitalization) capable of increasing significant carbon footprint, raising concerns about environmental sustainability in healthcare. Sustainable healthcare pol...

Full description

Saved in:
Bibliographic Details
Main Authors: Diego Bagnasco, Laura Pini, Benedetta Bondi, Carola Montagnino, Elisa Testino, Veronica Capuano, Celeste Pugliaro, Luisa Brussino, Stefania Nicola, Marco Caminati, Ilaria Baiardini, Fulvio Braido
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Series:Biomedicines
Subjects:
carbon footprint
severe asthma
biologics
CO<sub>2</sub>
environment
monoclonal antibodies
Online Access:https://www.mdpi.com/2227-9059/13/7/1574
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2227-9059/13/7/1574

Similar Items